IPP Bureau
Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
By IPP Bureau - April 13, 2022
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions
By IPP Bureau - April 13, 2022
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
Novel Covid-19 vaccine may protect the immunocompromised
By IPP Bureau - April 13, 2022
The peptide-based vaccine induces a t cell-dependent response
WeylChem inaugurates new multi-purpose custom manufacturing plant in France
By IPP Bureau - April 13, 2022
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Zydus to supply Sagent's caffeine citrate oral solution from Jarod
By IPP Bureau - April 13, 2022
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Venus Remedies gets CII's Responsible Export Organisation Certification
By IPP Bureau - April 13, 2022
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
By IPP Bureau - April 13, 2022
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Wacker, CordenPharma to produce mRNA vaccines for Germany
By IPP Bureau - April 12, 2022
Both companies have been selected for stand-by production by German government
One-dose HPV vaccine offers solid protection against cervical cancer
By IPP Bureau - April 12, 2022
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Jorge Gomez joins Moderna as Chief Financial Officer
By IPP Bureau - April 12, 2022
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Carestream installs DRX Compass at Gati Diagnostic Centre
By IPP Bureau - April 12, 2022
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
PhableCare raises Rs 187 crore in Series B funding
By IPP Bureau - April 12, 2022
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Dr. Morepen launches advanced muscle food
By IPP Bureau - April 12, 2022
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Aleor receives USFDA approval for Lidocaine and Prilocaine Cream
By IPP Bureau - April 12, 2022
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Pharmapack Europe 2022 to open on May 18-19 in Paris
By IPP Bureau - April 12, 2022
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
